Search

Ruben Papoian Phones & Addresses

  • Hillsboro, OR
  • 964 Auburnview Dr, Cincinnati, OH 45206
  • 964 Auburnview Dr APT 5, Cincinnati, OH 45206
  • 9348 Towne Square Ave, Cincinnati, OH 45242
  • Blue Ash, OH
  • 1125 NW 12Th Ave APT 1402, Portland, OR 97209

Work

Position: Professional/Technical

Resumes

Resumes

Ruben Papoian Photo 1

Ruben Papoian

View page
Position:
Director, Drug Discovery Center at University of Cincinnati
Location:
Cincinnati Area
Industry:
Higher Education
Work:
University of Cincinnati since Jul 2005
Director, Drug Discovery Center

Novartis AG Jan 2003 - Jan 2005
Program Director: VeloceGenomics: Functionalizaiton of Novel Therapuetic Proteins

Serono S.A. 1992 - 2004
Senior Scientist

Merck Serono 1992 - 2003
Senior Scientist, Project Coordinator Discovery
Education:
University of California, San Francisco - School of Medicine 1973 - 1979
Skills:
Building cost-effective process-based infrastructures to conduct and manage biomedical science and associated technologies
Interests:
Classical Music, Jazz, Avant-Garde Music, Literature, Modern/Contemporary Art, General Philosophy, Philosophy of Science, Language, Neurological Basis of Consciousness
Ruben Papoian Photo 2

Ruben Papoian

View page
Location:
6267 northeast Carillion Dr, Hillsboro, OR 97124
Industry:
Pharmaceuticals
Work:
University of Cincinnati Nov 1, 2013 - Sep 2015
Research Professor Retired

University of Cincinnati Jul 2005 - Jun 2013
Director Drug Discovery Center

Novartis 2003 - 2005
Program Director

Emd Serono, Inc. 1999 - 2003
Senior Scientist - Project Leader and Project Coordinator

Emd Serono, Inc. 2002 - 2003
Senior Scientist and Project Coordinator Discovery
Education:
University of California, San Francisco - School of Medicine 1973 - 1979
Doctorates, Doctor of Philosophy, Philosophy
The Collins College of Hospitality Management at Cal Poly Pomona 1964 - 1970
Bachelors, Bachelor of Science, Biology, Microbiology
Skills:
Drug Discovery
Assay Development
Animal Models
Multiple Sclerosis
Autoimmune Diseases
Immunology
Hts
Project Management
Project Coordination
Science
Biomarker Discovery
In Vitro
Research
High Throughput Screening
Life Sciences
Biotechnology
Cell Culture
Cell Biology
Cell
Pharmaceutical Industry
Ruben Papoian Photo 3

Director, Drug Discovery At Genome Research Institute, University Of Cincinnati

View page
Position:
Director, Drug Discovery at Genome Research Institute, University of Cincinnati
Location:
Cincinnati Area
Industry:
Pharmaceuticals
Work:
Genome Research Institute, University of Cincinnati
Director, Drug Discovery

Publications

Us Patents

Use Of Osteopontin For The Treatment And/Or Prevention Of Neurologic Diseases

View page
US Patent:
7297099, Nov 20, 2007
Filed:
Nov 5, 2004
Appl. No.:
10/981737
Inventors:
Ursula Boschert - Troinex, CH
Georg Feger - Thoiry, FR
Raghuram Selvaraju - Vandoeuvres, CH
Lilia Bernasconi - Perly, CH
Ruben Papoian - Cincinnati OH, US
Assignee:
Laboratoires Serono SA - Coinsins, Vaud
International Classification:
C07K 14/00
US Classification:
542 2, 530350
Abstract:
The invention relates to the use of osteopontin, or of an agonist of osteopontin activity, for treatment or prevention of a neurologic diseases.

Use Of Clusterin For The Treatment And/Or Prevention Of Peripheral Neurological Diseases

View page
US Patent:
20070134260, Jun 14, 2007
Filed:
Mar 26, 2004
Appl. No.:
10/550775
Inventors:
Georg Feger - Thoiry, FR
Ursula Boschert - Troinex, CH
Yves Sagot - Beumont, FR
Ruben Papoian - Cincinnati OH, US
International Classification:
A61K 39/00
US Classification:
424185100
Abstract:
The invention relates to the use of clusterin, or of an agonist of clusterin activity, for treatment or prevention of peripheral neurological diseases, The invention further relates to the use of a combination of clusterin and heparin, for treatment or prevention of peripheral neurological diseases.

Use Of Osteopontin For The Treatment And/Or Prevention Of Neurologic Diseases

View page
US Patent:
20070225214, Sep 27, 2007
Filed:
Feb 27, 2007
Appl. No.:
11/679735
Inventors:
Ursula Boschert - Troinex, CH
Georg Feger - Thoiry, FR
Raghuram Selvaraju - Vandoeuvres, CH
Lilia Bernasconi - Perly, CH
Ruben Papoian - Cincinnati OH, US
Assignee:
APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. - Curacao
International Classification:
A61K 38/16
US Classification:
514008000
Abstract:
The invention relates to the use of osteopontin, or of an agonist of osteopontin activity, for treatment or prevention of a neurologic diseases.

Identification Of Phospholipase A2 As Target In Cancer Treatment, With Special Emphasis On Colorectal Cancer And Its Mechanism Of Action

View page
US Patent:
20070298022, Dec 27, 2007
Filed:
Jan 12, 2006
Appl. No.:
11/813619
Inventors:
Andreas Scherer - Freiburg, DE
Ruben Papoian - Cincinnati OH, US
International Classification:
A61K 38/00
A61P 43/00
C12Q 1/42
C12Q 1/68
US Classification:
424094100, 435021000, 435006000
Abstract:
A peptide of phospholipase A2 had been detected in human plasma and synthesised. The peptide was injected into mice and gene expression profiling on many organs performed. Phospholipase A2 showed significant effects on regulation of gene expression in the liver. The genes affected are members of the integrin signalling pathway, wnt pathway and PTEN pathway. The changes in gene expression indicate a positive effect of phospholipase A2 on cell proliferation and invasiveness. The gene annotation points at colorectal cancer.

Use Of Osteopontin For The Treatment And/Or Prevention Of Neurologic Diseases

View page
US Patent:
20080213234, Sep 4, 2008
Filed:
Nov 7, 2007
Appl. No.:
11/936623
Inventors:
Ursula BOSCHERT - Troinex, CH
Georg Feger - Thoiry, FR
Raghuram Selvaraju - Vandoeuvres, CH
Lilia Bernasconi - Perly, CH
Ruben Papoian - Cincinnati OH, US
Assignee:
LABORATOIRES SERONO SA - Coinsins
International Classification:
A61K 48/00
A61P 25/00
US Classification:
424 9321, 514 44
Abstract:
The invention relates to the use of osteopontin, or of an agonist of osteopontin activity, for treatment or prevention of a neurologic diseases.

Use Of Osteopontin For The Treatment And/Or Prevention Of Neurologic Diseases

View page
US Patent:
7217687, May 15, 2007
Filed:
May 8, 2002
Appl. No.:
10/477876
Inventors:
Ursula Boschert - Troinex, CH
Georg Feger - Thoiry, FR
Raghuram Selvaraju - Vandoeuvres, CH
Lilia Bernasconi - Perly, CH
Ruben Papoian - Cincinnati OH, US
Assignee:
Applied Research Systems ARS Holding N.V. - Curacao
International Classification:
C07K 14/00
US Classification:
514 2, 530351
Abstract:
The invention relates to the use of osteopontin, or of an agonist of osteopontin activity, for treatment or prevention of a neurologic diseases.
Ruben Papoian from Hillsboro, OR, age ~79 Get Report